Paul D’Souza

Pharmaceutical Industry Analyst

Q3 2019 M&A highlights

We’ve recently wrapped up analysis of Q3 2019 M&A activity around the world.  Here are a few highlights: Q3 2019 new M&A volume and total deal value increased by 4% and 10%, respectively Total disclosed biopharma mergers and acquisitions (M&A) volume increased slightly in the third quarter of 2019, up 4% from 140 new M&As […]

Report: Biopharma licensing eclipsed $33 billion in Q2 2019

Earlier this year, we released an in-depth analysis of 2018 biopharma deals activity. Today’s blog examines more recent biopharma partnering activities, focusing on licensing deals in the second quarter of 2019.   Biopharma licensing booms with a 47% increase compared to Q2 2018 Total disclosed biopharma licensing exhibited strong growth in worldwide spend during the […]